Market Cap | 14.92M | P/E | - | EPS this Y | 50.00% | Ern Qtrly Grth | - |
Income | -25.55M | Forward P/E | -1.17 | EPS next Y | - | 50D Avg Chg | -20.00% |
Sales | 88.13M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -38.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -91.00% |
Recommedations | 3.00 | Quick Ratio | 0.17 | Shares Outstanding | 111.04M | 52W Low Chg | 41.00% |
Insider Own | 12.95% | ROA | 3.86% | Shares Float | 97.49M | Beta | 1.48 |
Inst Own | 13.83% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.13 |
Gross Margin | 50.04% | Profit Margin | -28.99% | Avg. Volume | 114,791 | Target Price | 0.45 |
Oper. Margin | 22.26% | Earnings Date | May 13 | Volume | 144,435 | Change | -6.63% |
Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.